XBL xceed biotechnology ltd

Keep an eye on XBL. Trying to break up from multi year base. Has...

  1. marsbar
    183 Posts.
    clock Created with Sketch.
    13/10/05
    14:34
    Post #: 1173676
    Keep an eye on XBL. Trying to break up from multi year base. Has about 10-11c cash per share. New CEO - Ex Metabolic, Axon and Circadian.
    Have been in exclusive negotiations with a major about their fully biodegradable stents. (Opens up arteries then once healed they biodegrade into natural compounds the body can absorb - better alternative to open heart surgery). This period is due to expire in November so I guess watch for insiders buying closer to mid-November.
    XBL Price at posting: 0.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
watchlist Created with Sketch. Add XBL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.